Publication date: 5 October 2017
Source:Cell Stem Cell, Volume 21, Issue 4
Author(s): Jiyung Shin, Jacob E. Corn
In this issue of Cell Stem Cell, Tothova et al. (2017) demonstrate a promising way to model the complex genetics of clonal hematopoiesis and myeloid disorders using CRISPR-Cas9 genome editing in human hematopoietic stem and progenitor cells. Their approach opens the door to genotype-specific pharmacologic testing.
Teaser
In this issue of Cell Stem Cell, Tothova et al. (2017) demonstrate a promising way to model the complex genetics of clonal hematopoiesis and myeloid disorders using CRISPR-Cas9 genome editing in human hematopoietic stem and progenitor cells. Their approach opens the door to genotype-specific pharmacologic testing.http://ift.tt/2y2Pyjz
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου